Journal of Neurocytology

, Volume 33, Issue 5, pp 479–488 | Cite as

Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro

  • Gerard W. O’Keeffe
  • Peter Dockery
  • Aideen M. Sullivan


Growth/differentiation factor 5 (GDF5) is a member of the transforming growth factor-β superfamily that is expressed in the developing CNS, including the ventral mesencephalon (VM). GDF5 has been shown to increase the survival of dopaminergic neurones in animal models of Parkinson’s disease. This study was aimed at characterising the effects of GDF5 on dopaminergic neurones in vitro. Treatment with GDF5 induced a three-fold increase in the number of dopaminergic neurones in embryonic day 14 rat VM cultures after six days in vitro. A significant increase was also observed in the numbers of astrocytes in GDF5-treated cultures. GDF5 treatment also had significant effects on the morphology of dopaminergic neurones in these cultures; total neurite length, number of branch points and somal area were all significantly increased after six days in vitro. Analysis of neurite length and numbers of branch points at each level of the neuritic field revealed that the most pronounced effects of GDF5 were on the secondary and tertiary levels of the neuritic field. The specific type I receptor for GDF5, bone morphogenetic protein receptor (BMPR)-Ib, was found to be strongly expressed in freshly-dissected E14 VM tissue, but its expression was lost with increasing time in culture. Accordingly, treatment with GDF5 for 24 h from the time of plating induced increases in the numbers of dopaminergic neurones, while treatment with GDF5 for 24 h after six days in vitro did not. This study shows that GDF5 can promote both the survival and morphological differentiation of VM dopaminergic neurones in vitro, lending support to its potential as a candidate dopaminergic neurotrophin for use in the treatment of Parkinson’s disease.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. ALTMAN, J. & BAYER, S. A. (1981) Development of the brain stem in the rat. V. Thymidine-radiographic study of the time of origin of neurons in the midbrain tegmentum. Journal of Comparative Neurology 198, 677–716.PubMedGoogle Scholar
  2. BALEMAN, W. & VAN HUL, W. (2002) Extracellular regulation of BMP signalling in vertebrates: A cocktail of modulators. Developmental Biology 250, 231–250.PubMedGoogle Scholar
  3. BAYER, S. A., WILLS, K. V., TRIARHOU, L. C. & GHETTI, B. (1995) Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Experimental Brain Research 105, 191–199.Google Scholar
  4. BOTTNER, M., SUTER-CRAZZOLARA, C., SCHOBER, A. & UNSICKER, K. (1999) Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell and Tissue Research 297, 103–110.PubMedGoogle Scholar
  5. BREDERLAU, A., FAIGLE, R., KAPLAN, P., ODIN, P. & FUNA, K. (2002) Bone morphogenetic proteins but not growth differentiation factors induce dopaminergic differentiation in mesencephalic precursors. Molecular and Cellular Neuroscience 21, 367–378.PubMedGoogle Scholar
  6. BUXTON, P., EDWARDS, C., ARCHER, C. W. & FRANCIS-WEST, P. (2001) Growth/differentiation factor-5 (GDF5) and skeletal development. Journal of Bone and Joint Surgery 83-A, S23–S30.PubMedGoogle Scholar
  7. CHARYTONIUK, D. A., TRAIFFORT, E., PINARD, E., ISSERTIAL, O., SEYLAZ, J. & RUAT, M. (2000) Distribution of bone morphogenetic protein and bone morphogenetic protein receptor transcripts in the rodent nervous system and up-regulation of bone morphogenetic protein receptor type II in hippocampal dentate gyrus in a rat model of global cerebral ischemia. Neuroscience 100, 33–43.PubMedGoogle Scholar
  8. CHEN, H. L., LEIN, P. J., WANG, J. Y., GASH, D., HOFFER, B. J. & CHIANG, Y. H. (2003) Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals. Brain Research 994, 81–90.PubMedGoogle Scholar
  9. DE CAESTECKER, M. (2004) The transforming growth factor-beta superfamily of receptors. Cytokine and Growth Factor Reviews 15, 1–11.PubMedGoogle Scholar
  10. EBENDAL, T, BENGTSSON, H. & SODERSTROM, S. (1998) Bone morphogenetic proteins and their receptors: Potential functions in the brain. Journal of Neuroscience Research 51, 39–146.Google Scholar
  11. EDWARDS, C. J. & FRANCIS-WEST, P. H. (2001) Bone morphogenetic proteins in the development and healing of synovial joints. Seminars in Arthritis and Rheumatitis 31, 33–42.Google Scholar
  12. FARKAS, L. M., DUNKER, N., ROUSSA, E., UNSICKER, K. & KRIEGLSTEIN, K. (2003) Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. Journal of Neuroscience 23, 5178–5186.PubMedGoogle Scholar
  13. GRANHOLM, A. C., MOTT, J. L., BOWENKAMP, K., EKEN, S., HENRY, S., HOFFER, B. J., LAPCHAK, P., PALMER, M. R., VAN HORNE, C. & GERHARDT, G. A. (1997) Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Experimental Brain Research 116, 29–38.Google Scholar
  14. GRATACOS, E., CHECA, N. & ALBERCH, J. (2001) Bone morphogenetic protein-2, but not bone morphogenetic protein-7, promotes dendritic growth and calbindin phenotype in cultured rat striatal neurons. Neuroscience 104, 783–790.PubMedGoogle Scholar
  15. HOU, J. G., LIN, L. F. & MYTILINEOU, C. (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. Journal of Neurochemistry 66, 74–82.PubMedGoogle Scholar
  16. HURLEY, F. M., COSTELLO, D. J. & SULLIVAN, A. M. (2004) Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson’s disease. Experimental Neurology 185, 281–289.PubMedGoogle Scholar
  17. JORDAN, J., BOTTNER, M., SCHLUESENER, H. J., UNSICKER, K. & KRIEGLSTEIN, K. (1997) Bone morphogenetic proteins: Neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. European Journal of Neuroscience 9, 1699–1709.PubMedGoogle Scholar
  18. KNIGHT, P. G. & GLISTER, C. (2003) Local roles of TGF-beta superfamily members in the control of ovarian follicle development. Animal Reproduction Science 78, 165–183.PubMedGoogle Scholar
  19. KRIEGLSTEIN, K., SUTER-CRAZZOLARA, C., HOTTEN, G., POHL, J. & UNSICKER, K. (1995a) Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons. Journal of Neuroscience Research 42, 724–732.Google Scholar
  20. KRIEGLSTEIN, K., SUTER-CRAZZOLARA, C., FISCHER, W. H. & UNSICKER, K. (1995b) TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO Journal 14, 736–742.Google Scholar
  21. LEE, S. J. (1991) Expression of growth/differentiation factor 1 in the nervous system: Conservation of a bicistronic structure. Proceedings of the National Academy of Sciences USA 88, 4250–4254.Google Scholar
  22. LIN, L. F., DOHERTY, D. H., LILE, J. D., BEKTESH, S. & COLLINS, F. (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 130–132.Google Scholar
  23. LINGOR, P., UNSICKER, K. & KRIEGLSTEIN, K. (1999) Midbrain dopaminergic neurons are protected from radical induced damage by GDF5 application. Journal of Neural Transmission 106, 139–144.PubMedGoogle Scholar
  24. LUYTEN, F. P. (1997) Cartilage-derived morphogenetic protein-1. International Journal of Biochemistry and Cell Biology 29, 1241–1244.PubMedGoogle Scholar
  25. MAYHEW, T. M. (1991) The new stereological methods for interpreting functional morphology from slices of cells and organs. Experimental Physiology 21, 313–328.Google Scholar
  26. MEHLER, M. F., MABIE, P. C., ZHANG, D. & KESSLER, J. A. (1997) Bone morphogenetic proteins in the nervous system. Trends in Neurosciences 20, 309–317.PubMedGoogle Scholar
  27. MING, J. E., ELKAN, M., TANG, K. & GOLDEN, J. A. (2002) Type I bone morphogenetic protein receptors are expressed on cerebellar granular neurons and a constitutively active form of the type IA receptor induces cerebellar abnormalities. Neuroscience 114, 849–857.PubMedGoogle Scholar
  28. NAKASHIMA, M., TOYONO, T., AKAMINE, A. & JOYNER, A. (1999) Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis. Mechanisms of Development 80, 185–189.PubMedGoogle Scholar
  29. NISHITOH, H., ICHIJO, H., KIMURA, M., MATSUMOTO, T., MAKISHIMA, F., YAMAGUCHI, A., YAMASHITA, H., ENOMOTO, S. & MIYAZONO, K. (1996) Identification of type I and type II serine/threonine kinase receptors for growth/ differentiation factor-5. Journal of Biological Chemistry 271, 21345–21352.PubMedGoogle Scholar
  30. O’KEEFFE, G. W., HANKE, M., POHL, J. & SULLIVAN, A. M. (2004) Expression of growth differentiation factor-5 in the developing and adult rat brain. Developmental Brain Research 151, 199–202.PubMedGoogle Scholar
  31. PANCHISION, D. M., PICKEL, J. M., STUDER, L., LEE, S. H., TURNER, P. A., HAZEL, T. G. & MCKAY, R. D. (2001) Sequential actions of BMP receptors control neural precursor cell production and fate. Genes and Development 15, 2094–2110.PubMedGoogle Scholar
  32. ROSENBLAD, C., MARTINEZ-SERRANO, A. & BJORKLUND, A. (1996) Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75, 979–985.PubMedGoogle Scholar
  33. SCHOBER, A., BOTTNER, M., STRELAU, J., KINSCHERF, R., BONATERRA, G. A., BARTH, M., SCHILLING, L., FAIRLIE, W. D., BREIT, S. N. & UNSICKER, K. (2001) Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. Journal of Comparative Neurology 439, 32–45.PubMedGoogle Scholar
  34. SODERSTROM, S., BENGTSSON, H. & EBENDAL, T. (1996) Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain. Cell and Tissue Research 286, 269–279.PubMedGoogle Scholar
  35. SODERSTROM, S. & EBENDAL, T. (1999) Localized expression of BMP and GDF mRNA in the rodent brain. Journal of Neuroscience Research 56, 482–492.PubMedGoogle Scholar
  36. STORM, E. E., HUYNH, T. V., COPELAND, N. G., JENKINS, N. A., KINGSLEY, D. M. & LEE, S. J. (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368, 639–643.CrossRefPubMedGoogle Scholar
  37. STRELAU, J., SULLIVAN, A., BOTTNER, M., LINGOR, P., FALKENSTEIN, P., SUTER-CRAZZOLARA, C., GALTER, D., JASZAI, J., KRIEGLSTEIN, K. & UNSICKER, K. (2000) Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. Journal of Neuroscience 20, 8597–8603.PubMedGoogle Scholar
  38. SULLIVAN, A. M., OPACKA-JUFFRY, J., HOTTEN, G., POHL, J. & BLUNT, S. B. (1997) Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson’s disease. Neuroscience Letters 233, 73–76.PubMedGoogle Scholar
  39. SULLIVAN, A. M., POHL, J. & BLUNT, S. B. (1998) Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson’s disease. European Journal of Neuroscience 10, 3681–3688.PubMedGoogle Scholar
  40. SULLIVAN, A. M., OPACKA-JUFFRY, J., POHL, J. & BLUNT, S. B. (1999) Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration. Brain Research 818, 176–179.PubMedGoogle Scholar
  41. Sullivan, A. M. & O’Keeffe, G. W. (2005) The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: Relevance to Parkinson’s disease. Journal of Anatomy (in press).Google Scholar
  42. THOMAS, J. T., LIN, K., NANDEDKAR, M., CAMARGO, M., CERVENKA, J. & LUYTEN, F. P. (1996) A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nature Genetics 12, 315–317.PubMedGoogle Scholar
  43. TOMIZAWA, K., MATSUI, H., KONDO, E., MIYAMOTO, K., TOKUDA, M., ITANO, T., NAGAHATA, S., AKAGI, T. & HATASE, O. (1995) Developmental alteration and neuron-specific expression of bone morphogenetic protein-6 (BMP-6) mRNA in rodent brain. Molecular Brain Research 28, 122–128.PubMedGoogle Scholar
  44. VOKES, S. A. & KRIEG, P. A. (2000) Gdf-16, a novel member of the growth/differentiation factor subgroup of the TGF-b superfamily, is expressed in the hindbrain and epibranchial placodes. Mechanisms of Development 95, 279–282.PubMedGoogle Scholar
  45. WANG Y., TIEN L. T., LAPCHAK, P. A. & HOFFER, B. J. (1996) GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Cell and Tissue Research 286, 225–233.PubMedGoogle Scholar
  46. WATAKABE, A., FUJITA, H., HAYASHI & M., YAMAMORI, T. (2001) Growth/differentiation factor 7 is preferentially expressed in the primary motor area of the monkey neocortex. Journal of Neurochemistry 76, 1455–1464.PubMedGoogle Scholar
  47. WIDMER, H. R., SCHALLER, B., MEYER, M. & SEILER, R. W. (2000) Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons. Experimental Neurology 164, 71– 81.CrossRefPubMedGoogle Scholar
  48. WOOD, T. K., SULLIVAN, A. M. & MCDERMOTT, K. W. (2003) Viability of dopaminergic neurones is influenced by serum and astroglial cells in vitro. Journal of Neurocytology 32, 97–103.CrossRefPubMedGoogle Scholar
  49. Wood, T. K., Mcdermott, K. W. & sullivan, A. M. (2005) Differential effects of GDF5 and GDNF on dopaminergic neurones and astroglia in cultures of embryonic rat midbrain. Journal of Neuroscience Research (in press).Google Scholar
  50. ZHANG, D., MEHLER, M. F., SONG, Q. & KESSLER, J. A. (1998) Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression. Journal of Neuroscience 9, 3314–3326.Google Scholar
  51. ZHAO, R., LAWLER, A. M. & LEE, S. J. (1999) Characterization of GDF-10 expression patterns and null mice. Developmental Biology 212, 68–79.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2004

Authors and Affiliations

  • Gerard W. O’Keeffe
    • 1
  • Peter Dockery
    • 1
  • Aideen M. Sullivan
    • 1
  1. 1.Department of Neuroscience/Anatomy, Biosciences Research InstituteNational University of Ireland Cork (NUIC)CorkIreland

Personalised recommendations